Chengdu huasun technology group Inc. , LTD. (000790.SZ)

3.5400 -0.0300 (-0.84%) As of 01:21PM CST. Market open.

Chengdu huasun technology group Inc. , LTD.

No. 1168, Shuxin Avenue
Chengdu High-tech Zone (West District)
Chengdu 611731
China

https://www.huasungrp.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 857

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mingliang Huang	Chairman & GM	N/A	N/A	1968
Mr. Jun Li	Financial Director	N/A	N/A	1980
Mr. Duoxue Wang	Deputy GM & Non-Independent Director	N/A	N/A	1984
Ms. Ping Yang	Director and Deputy GM	N/A	N/A	1982
Mr. Lingxing Kong	Deputy General Manager	N/A	N/A	1973
Mr. Hailei Diao	Board Secretary	N/A	N/A	1977
Mr. Fang Wan	Vice President	N/A	N/A	N/A
Mr. Jian Hua Li	Vice President	N/A	N/A	N/A

Amounts are as of 31 December 2014, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of cardiovascular and cerebrovascular diseases. In addition, the company designs, produces, installs, and services steel structure buildings. The company was formerly known as Chengdu Taihe Health Technology Group Inc., Ltd. and changed its name to Chengdu huasun technology group Inc. , LTD. in April 2020. The company was founded in 1988 and is based in Chengdu, China.

Corporate governance

Chengdu huasun technology group Inc. , LTD.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.